Altor Fund IV (‘‘Altor’’) has entered into an agreement to divest Hamlet Protein (‘‘Hamlet’’), a leading provider of specialty soy-based ingredients for young animal nutrition, to Royal Agrifirm Group ‘‘Agrifirm’’), a Dutch cooperative with a strong global presence in agricultural solutions.
Altor invested in Hamlet in 2015 with the ambition to accelerate the company’s growth and strengthen its position as a global provider of high-quality soy-based specialty ingredients for young animals. During the ownership period, the company has faced changing market dynamics and multiple external challenges, despite this Hamlet has continued to develop its product and geographical coverage, built a strong operational platform for future growth and maintained its strong focus on R&D and product quality.
“We have had a very good partnership with management over the past years and have appreciated their strong commitment to building on Hamlet’s core strength while successfully navigating an uncertain macro environment. We are now pleased to have found a good long-term strategic owner in Agrifirm that is well positioned to support Hamlet in its next chapter,” said Søren Johansen, Partner at Altor.
“Altor has been an active and engaged owner, consistently supporting us through both opportunities and challenges over the past decade. I am proud of the business and organization we have built together, I look forward to working together with Agrifirm on taking Hamlet to its next level. With Agrifirm’s deep industry expertise I am confident we will achieve fantastic things together,” said Erik Visser, CEO of Hamlet.
Closing of the transaction is subject to customary regulatory approvals.
